Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
UNH holding history
UnitedHealth Group Inc in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UNH overviewAll 13F holders of UNHFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −34,600−100.0% | Sold out | Holders |
| Q2 2025 | 34,600 | $10.8M | 0.9% | +11,820+51.9% | Added | Holders |
| Q1 2025 | 22,780 | $11.9M | 1.0% | −5,600−19.7% | Reduced | Holders |
| Q4 2024 | 28,380 | $14.4M | 1.2% | +23,800+519.7% | Added | Holders |
| Q3 2024 | 4,580 | $2.68M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 4,580 | $2.33M | 0.2% | −25,800−84.9% | Reduced | Holders |
| Q1 2024 | 30,380 | $15.0M | 1.0% | +5,600+22.6% | Added | Holders |
| Q4 2023 | 24,780 | $13.0M | 0.9% | 00.0% | Unchanged | Holders |
| Q3 2023 | 24,780 | $12.5M | 1.0% | −37,050−59.9% | Reduced | Holders |
| Q2 2023 | 61,830 | $29.7M | 2.1% | −11,100−15.2% | Reduced | Holders |
| Q1 2023 | 72,930 | $34.5M | 2.0% | −22,280−23.4% | Reduced | Holders |
| Q4 2022 | 95,210 | $50.5M | 2.7% | +1,100+1.2% | Added | Holders |
| Q3 2022 | 94,110 | $47.5M | 2.8% | +2,400+2.6% | Added | Holders |
| Q2 2022 | 91,710 | $47.1M | 2.8% | +700+0.8% | Added | Holders |
| Q1 2022 | 91,010 | $46.4M | 2.3% | +34,300+60.5% | Added | Holders |
| Q4 2021 | 56,710 | $28.5M | 1.3% | +1,110+2.0% | Added | Holders |
| Q3 2021 | 55,600 | $21.7M | 1.1% | +7,700+16.1% | Added | Holders |
| Q2 2021 | 47,900 | $19.2M | 0.9% | +2,000+4.4% | Added | Holders |
| Q1 2021 | 45,900 | $17.1M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.